SSZ 1000mg Tablet DR
Marketer
Cucard Pharma
Salt Composition
Sulfasalazine (1000mg)
Overview SSZ 1000mg Tablet DR
Sulfasalazine 1000mg extended-release tablets treat diverse inflammatory disorders affecting the joints (rheumatoid, psoriatic, and ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis and Crohn's disease). Administer this medication with food to minimize stomach upset. Consistent daily dosing at the same time maximizes therapeutic efficacy. Continue the prescribed regimen as directed, even after symptom improvement. Adequate hydration helps prevent renal complications, such as kidney stones. Common adverse reactions include nausea, headache, anorexia, vomiting, diarrhea, and gastrointestinal distress. Persisting or worsening side effects warrant immediate medical attention; your physician can offer strategies for symptom management. Prior to commencing therapy, inform your doctor of any pre-existing cardiac, renal, or hepatic conditions, as well as all other medications. Regular blood tests monitoring kidney and liver function, along with blood cell counts, may be recommended. Pregnant or lactating individuals should seek medical counsel before initiating treatment.
Primary Ingredients of SSZ 1000mg Tablet DR
There is no text provided to rephrase.
Uses of SSZ 1000mg Tablet DR
Management of rheumatoid arthritis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and psoriatic arthritis.
Major Benefits of SSZ 1000mg Tablet DR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The SSZ 1000mg Tablet DR should be administered with a meal.
Common Side effects of SSZ 1000mg Tablet DR:
- Diarrhea
- Gastrointestinal discomfort
- Headache
- Loss of appetite
- Nausea
- Oligospermia (low sperm count)
- Vomiting
How to use SSZ 1000mg Tablet DR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The SSZ 1000mg Tablet DR should be administered with a meal.
How SSZ 1000mg Tablet DR works:
The extended-release SSZ 1000mg tablet is classified as a disease-modifying antirheumatic drug (DMARD). Its mechanism involves dampening excessive immune responses characteristic of autoimmune disorders, thereby inhibiting the inflammatory mediators responsible for swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and SSZ 1000mg Tablet DR is unsafe.
PregnancySAFE IF PRESCRIBED
The use of 1000mg DR SSZ tablets is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
Administration of 1000mg delayed-release SSZ tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 1000mg sustained-release SSZ tablet.
KidneyCAUTION
The extended-release 1000mg SSZ tablet requires careful administration for individuals with impaired kidney function. Dosage modification of the 1000mg extended-release SSZ tablet may be necessary. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment.
LiverUNSAFE
The use of 1000mg sustained-release SSZ tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take SSZ 1000mg Tablet DR :
Should you forget to take your SSZ 1000mg Tablet DR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About SSZ 1000mg Tablet DR
| Label | Value |
|---|---|
| Chemical Type | Salicylic Acid Derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Non-biologic Disease-Modifying Antirheumatic Drugs (DMARDs) |
3,018 People bought this recently